Company Data

Prime Medicine Inc.

Ticker
PRME
Current Price
$1.23 5.58%
Market Cap
$161.5M
Price Target
Refer to Report
Volume
1.2M
52wk Range
$1.11 - $8.27
Advanced Market Data

Overview

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy